Biotechnology
The Biotechnology industry has a total of 584 stocks, with a combined market cap of $1.23 trillion and total revenue of $109.16 billion.
Market Cap
1.23T
Revenue
109.16B
Profits
-41.15B
PE Ratio
n/a
Profit Margin
-37.69%
Dividend Yield
0.04%
584 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 123.26B | -0.08% | 1,568,123 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 68.85B | -0.33% | 648,400 | 14.92B |
| 3 | ARGX | argenx SE | 53.83B | 0.30% | 277,704 | 4.74B |
| 4 | RVMD | Revolution Medicines, Inc. | 39.58B | 3.90% | 1,832,639 | - |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.71B | -5.54% | 1,378,519 | 4.29B |
| 6 | ONC | BeOne Medicines AG | 34.69B | -1.70% | 428,134 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 33.50B | -0.60% | 2,540,469 | 2.44B |
| 8 | ROIV | Roivant Sciences Ltd. | 24.82B | 1.71% | 3,834,610 | 8.26M |
| 9 | MRNA | Moderna, Inc. | 24.53B | -2.11% | 4,551,992 | 2.23B |
| 10 | INSM | Insmed Incorporated | 23.48B | 0.80% | 2,002,885 | 819.56M |
| 11 | INCY | Incyte Corporation | 23.42B | 0.51% | 2,232,513 | 5.36B |
| 12 | BNTX | BioNTech SE | 23.13B | -0.09% | 1,131,173 | 3.23B |
| 13 | GMAB | Genmab A/S | 17.56B | -0.90% | 2,629,331 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.21B | 0.46% | 668,250 | 998.25M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 15.95B | 1.34% | 1,442,647 | 579.96M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.55B | 2.21% | 503,559 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 14.06B | 0.43% | 2,555,562 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.76B | 1.46% | 528,310 | 1.13B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 11.84B | -2.97% | 878,315 | 708.24M |
| 20 | ABVX | ABIVAX Société Anonyme | 11.76B | -0.81% | 1,408,312 | 5.67M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.52B | -0.68% | 1,605,700 | 3.24B |
| 22 | TECH | Bio-Techne Corporation | 11.24B | 0.49% | 3,076,479 | 1.21B |
| 23 | CYTK | Cytokinetics, Incorporated | 10.89B | -0.22% | 1,588,489 | 105.82M |
| 24 | SMMT | Summit Therapeutics Inc. | 10.72B | 0.36% | 2,841,079 | - |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.47B | 4.09% | 3,775,226 | 622.01M |
| 26 | KRYS | Krystal Biotech, Inc. | 10.46B | 3.82% | 683,084 | 417.30M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.04B | -0.06% | 1,875,282 | - |
| 28 | CORT | Corcept Therapeutics Incorporated | 9.72B | 0.89% | 1,893,054 | 769.10M |
| 29 | KYMR | Kymera Therapeutics, Inc. | 9.52B | 1.56% | 720,688 | 51.48M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 9.23B | 0.35% | 1,482,552 | 1.51B |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.06B | 6.73% | 519,117 | 74.06M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 8.99B | -0.48% | 2,572,809 | 1.06B |
| 33 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.84B | -0.06% | 5,373,713 | 18.07M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 8.81B | 6.49% | 1,091,487 | - |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 8.77B | 2.01% | 282,211 | 7.46M |
| 36 | IMVT | Immunovant, Inc. | 8.27B | 3.34% | 882,225 | - |
| 37 | PCVX | Vaxcyte, Inc. | 8.12B | 0.29% | 1,128,025 | - |
| 38 | IBRX | ImmunityBio, Inc. | 8.04B | 3.09% | 9,025,459 | 140.98M |
| 39 | TGTX | TG Therapeutics, Inc. | 7.78B | -0.11% | 3,408,548 | 700.35M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.31B | 0.48% | 773,302 | 217.17M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 7.25B | 1.28% | 435,891 | 569.61M |
| 42 | COGT | Cogent Biosciences, Inc. | 6.68B | 3.00% | 1,914,573 | - |
| 43 | ERAS | Erasca, Inc. | 6.65B | 0.79% | 6,704,607 | - |
| 44 | XENE | Xenon Pharmaceuticals Inc. | 6.60B | 1.91% | 1,342,611 | 7.50M |
| 45 | PTCT | PTC Therapeutics, Inc. | 6.52B | 0.09% | 704,131 | 827.11M |
| 46 | CGON | CG Oncology, Inc. | 6.34B | 3.38% | 1,058,944 | 5.07M |
| 47 | SRRK | Scholar Rock Holding Corporation | 6.33B | 2.18% | 811,946 | - |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 6.01B | 2.34% | 278,328 | 274.48M |
| 49 | BLTE | Belite Bio, Inc | 5.90B | -0.39% | 155,023 | - |
| 50 | DFTX | Definium Therapeutics, Inc. | 5.88B | 0.43% | 1,487,083 | - |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 5.77B | 10.75% | 1,025,195 | 1.34M |
| 52 | ORKA | Oruka Therapeutics, Inc. | 5.59B | 11.63% | 2,804,782 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.27B | 2.59% | 1,475,503 | 536.20M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.71B | -1.63% | 1,620,300 | 4.10M |
| 55 | CAI | Caris Life Sciences, Inc. | 4.66B | 0.06% | 3,294,607 | 907.29M |
| 56 | MANE | Veradermics, Incorporated | 4.65B | 5.19% | 951,413 | - |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 4.38B | -0.12% | 1,207,376 | 1.10B |
| 58 | RLAY | Relay Therapeutics, Inc. | 4.34B | 2.79% | 2,157,335 | 10.68M |
| 59 | CELC | Celcuity Inc. | 4.31B | 0.10% | 1,310,305 | - |
| 60 | LEGN | Legend Biotech Corporation | 4.31B | -1.98% | 1,807,542 | 1.14B |
| 61 | VKTX | Viking Therapeutics, Inc. | 4.31B | 1.95% | 1,922,446 | - |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 4.28B | 4.11% | 744,699 | - |
| 63 | TNGX | Tango Therapeutics, Inc. | 4.13B | 3.33% | 2,289,892 | 56.99M |
| 64 | DYN | Dyne Therapeutics, Inc. | 3.92B | 4.49% | 1,537,920 | - |
| 65 | PBLS | Parabilis Medicines, Inc. | 3.76B | 1.69% | 472,532 | - |
| 66 | ELVN | Enliven Therapeutics, Inc. | 3.71B | 4.60% | 818,038 | - |
| 67 | NAMS | NewAmsterdam Pharma Company N.V. | 3.70B | 2.03% | 704,411 | 22.57M |
| 68 | DNLI | Denali Therapeutics Inc. | 3.70B | 2.46% | 1,611,465 | - |
| 69 | ALMS | Alumis Inc. | 3.65B | 5.25% | 1,001,235 | 8.40M |
| 70 | TLX | Telix Pharmaceuticals Limited | 3.58B | -3.42% | 132,193 | 803.79M |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 3.56B | 2.70% | 1,265,377 | 415.62M |
| 72 | GPCR | Structure Therapeutics Inc. | 3.45B | 5.32% | 915,201 | - |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.44B | 2.74% | 781,581 | 236.00M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 3.42B | 0.22% | 938,876 | 225.27M |
| 75 | MBX | MBX Biosciences, Inc. | 2.99B | 7.89% | 898,470 | - |
| 76 | IRON | Disc Medicine, Inc. | 2.91B | 3.65% | 243,190 | - |
| 77 | RARE | Ultragenyx Pharmaceutical Inc. | 2.87B | -3.11% | 1,500,530 | 670.00M |
| 78 | CLDX | Celldex Therapeutics, Inc. | 2.77B | -0.14% | 1,149,061 | 865.00K |
| 79 | QURE | uniQure N.V. | 2.77B | 2.26% | 958,200 | 18.09M |
| 80 | VERA | Vera Therapeutics, Inc. | 2.76B | -1.58% | 1,390,187 | - |
| 81 | BEAM | Beam Therapeutics Inc. | 2.74B | -3.03% | 1,912,917 | 164.01M |
| 82 | TRVI | Trevi Therapeutics, Inc. | 2.71B | 9.85% | 8,312,192 | - |
| 83 | ATAI | AtaiBeckley Inc. | 2.67B | 0.98% | 41,848,899 | 3.49M |
| 84 | KOD | Kodiak Sciences Inc. | 2.66B | 3.37% | 491,666 | - |
| 85 | SLS | SELLAS Life Sciences Group, Inc. | 2.59B | 12.26% | 11,293,042 | - |
| 86 | TARS | Tarsus Pharmaceuticals, Inc. | 2.57B | 3.74% | 971,198 | 535.08M |
| 87 | IMNM | Immunome, Inc. | 2.53B | 0.54% | 688,485 | 4.02M |
| 88 | PHVS | Pharvaris N.V. | 2.44B | 3.80% | 236,448 | - |
| 89 | KLRA | Kailera Therapeutics, Inc. | 2.40B | 1.26% | 342,892 | - |
| 90 | NRIX | Nurix Therapeutics, Inc. | 2.40B | 0.22% | 794,891 | 36.77M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | 0.04% | 645,894 | - |
| 92 | VCEL | Vericel Corporation | 2.38B | -2.45% | 472,154 | 292.09M |
| 93 | AGIO | Agios Pharmaceuticals, Inc. | 2.36B | 2.30% | 773,957 | 66.05M |
| 94 | BHVN | Biohaven Ltd. | 2.32B | 8.96% | 3,506,224 | - |
| 95 | NKTR | Nektar Therapeutics | 2.31B | 1.80% | 538,398 | 55.63M |
| 96 | COAG | Hemab Therapeutics Holdings, Inc. | 2.30B | 10.69% | 320,016 | - |
| 97 | ZLAB | Zai Lab Limited | 2.27B | -2.65% | 958,634 | 453.28M |
| 98 | PVLA | Palvella Therapeutics, Inc. | 2.26B | 6.41% | 258,338 | - |
| 99 | IOVA | Iovance Biotherapeutics, Inc. | 2.23B | 7.30% | 23,478,579 | 285.61M |
| 100 | SION | Sionna Therapeutics, Inc. | 2.23B | 9.10% | 1,139,315 | - |
| 101 | MESO | Mesoblast Limited | 2.21B | -3.02% | 399,248 | 65.38M |
| 102 | GLUE | Monte Rosa Therapeutics, Inc. | 2.07B | 6.04% | 1,220,500 | 42.95M |
| 103 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | 0.13% | 788,998 | 298.30M |
| 104 | RAPP | Rapport Therapeutics, Inc. | 2.04B | 6.20% | 470,125 | 20.00M |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 2.02B | 0.40% | 1,061,475 | 217.17M |
| 106 | NUVB | Nuvation Bio Inc. | 2.02B | 2.84% | 3,605,430 | 143.05M |
| 107 | ADMA | ADMA Biologics, Inc. | 2.02B | -1.14% | 5,589,557 | 509.86M |
| 108 | VRDN | Viridian Therapeutics, Inc. | 1.99B | - | 2,124,402 | 70.92M |
| 109 | ABCL | AbCellera Biologics Inc. | 1.97B | 4.95% | 4,229,381 | 79.21M |
| 110 | GHRS | GH Research PLC | 1.97B | -1.44% | 637,507 | - |
| 111 | OCUL | Ocular Therapeutix, Inc. | 1.96B | -2.18% | 1,880,853 | 52.04M |
| 112 | LKFT | Lakefront Biotherapeutics NV | 1.96B | 1.39% | 480,807 | 1.20B |
| 113 | URGN | UroGen Pharma Ltd. | 1.96B | 0.57% | 1,265,323 | 140.49M |
| 114 | HRMY | Harmony Biosciences Holdings, Inc. | 1.96B | 0.72% | 705,259 | 899.11M |
| 115 | DMRA | Damora Therapeutics, Inc. | 1.94B | 4.10% | 489,024 | - |
| 116 | NBTX | Nanobiotix S.A. | 1.91B | 0.69% | 218,729 | 38.27M |
| 117 | TYRA | Tyra Biosciences, Inc. | 1.91B | 1.65% | 621,567 | - |
| 118 | TSHA | Taysha Gene Therapies, Inc. | 1.91B | -0.17% | 2,849,252 | 7.47M |
| 119 | KARD | Kardigan, Inc. | 1.89B | 0.52% | 413,364 | - |
| 120 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.87B | 2.12% | 2,845,188 | 204.73M |
| 121 | ZBIO | Zenas BioPharma, Inc. | 1.86B | 4.57% | 769,461 | 10.00M |
| 122 | BCAX | Bicara Therapeutics Inc. | 1.82B | 0.58% | 471,678 | - |
| 123 | SRPT | Sarepta Therapeutics, Inc. | 1.82B | -0.06% | 5,399,160 | 2.18B |
| 124 | STOK | Stoke Therapeutics, Inc. | 1.81B | -0.21% | 413,964 | 32.08M |
| 125 | IMCR | Immunocore Holdings plc | 1.78B | 1.42% | 578,207 | 412.81M |
| 126 | PGEN | Precigen, Inc. | 1.76B | - | 2,967,831 | 31.60M |
| 127 | GENB | Generate Biomedicines, Inc. | 1.74B | -0.73% | 343,674 | 30.30M |
| 128 | ZYME | Zymeworks Inc. | 1.73B | - | 444,694 | 81.26M |
| 129 | ANAB | AnaptysBio, Inc. | 1.72B | 7.11% | 732,652 | 232.39M |
| 130 | MPLT | MapLight Therapeutics, Inc. | 1.72B | 1.75% | 778,797 | - |
| 131 | AAPG | Ascentage Pharma Group International | 1.71B | -8.14% | 12,127 | 82.08M |
| 132 | FTRE | Fortrea Holdings Inc. | 1.68B | -0.89% | 938,512 | 2.71B |
| 133 | MLTX | MoonLake Immunotherapeutics | 1.63B | 3.52% | 726,276 | - |
| 134 | INVA | Innoviva, Inc. | 1.60B | -2.25% | 541,150 | 420.69M |
| 135 | VIR | Vir Biotechnology, Inc. | 1.59B | 0.32% | 1,739,896 | 65.50M |
| 136 | NTLA | Intellia Therapeutics, Inc. | 1.59B | -4.09% | 4,329,238 | 66.09M |
| 137 | RXRX | Recursion Pharmaceuticals, Inc. | 1.56B | -2.48% | 19,353,221 | 66.41M |
| 138 | MAZE | Maze Therapeutics, Inc. | 1.56B | 3.50% | 335,931 | 20.00M |
| 139 | AVBP | ArriVent BioPharma, Inc. | 1.55B | 1.31% | 839,974 | - |
| 140 | SEPN | Septerna, Inc. | 1.51B | 5.83% | 306,430 | 72.26M |
| 141 | ABSI | Absci Corporation | 1.41B | 0.79% | 3,719,042 | 1.84M |
| 142 | SVRA | Savara Inc. | 1.40B | - | 1,010,598 | - |
| 143 | AKTS | Aktis Oncology, Inc. | 1.38B | -0.52% | 260,632 | 8.28M |
| 144 | NVAX | Novavax, Inc. | 1.35B | -0.36% | 2,265,585 | 596.34M |
| 145 | IMTX | Immatics N.V. | 1.31B | 2.02% | 401,112 | 43.00M |
| 146 | XNCR | Xencor, Inc. | 1.30B | 16.86% | 1,684,195 | 97.36M |
| 147 | ARDX | Ardelyx, Inc. | 1.28B | 1.36% | 3,274,381 | 427.68M |
| 148 | INBX | Inhibrx Biosciences, Inc. | 1.28B | -1.89% | 272,117 | 1.30M |
| 149 | TRAX | First Tracks Biotherapeutics, Inc. | 1.27B | 0.84% | 696,109 | - |
| 150 | AVLN | Avalyn Pharma Inc. | 1.25B | 10.20% | 364,052 | - |
| 151 | CRVS | Corvus Pharmaceuticals, Inc. | 1.25B | 4.41% | 780,733 | - |
| 152 | MNKD | MannKind Corporation | 1.25B | -0.25% | 3,508,985 | 360.78M |
| 153 | JBIO | Jade Biosciences, Inc. | 1.24B | 1.86% | 659,521 | - |
| 154 | DRTS | Alpha Tau Medical Ltd. | 1.22B | 14.06% | 1,103,042 | - |
| 155 | FBRX | Forte Biosciences, Inc. | 1.19B | 8.60% | 595,918 | - |
| 156 | MGTX | MeiraGTx Holdings plc | 1.15B | 0.89% | 461,080 | 79.76M |
| 157 | CAPR | Capricor Therapeutics, Inc. | 1.13B | 1.67% | 1,165,293 | 11.13M |
| 158 | WVE | Wave Life Sciences Ltd. | 1.12B | 2.65% | 2,120,299 | 71.80M |
| 159 | SPTX | Seaport Therapeutics, Inc. | 1.12B | 6.81% | 72,311 | - |
| 160 | EYPT | EyePoint, Inc. | 1.12B | 1.99% | 1,283,890 | 7.61M |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 1.11B | - | 1,667,483 | - |
| 162 | CGEM | Cullinan Therapeutics, Inc. | 1.09B | 7.80% | 594,761 | - |
| 163 | IVA | Inventiva S.A. | 1.08B | 2.21% | 862,365 | 7.94M |
| 164 | ANRO | Alto Neuroscience, Inc. | 1.07B | 0.77% | 777,370 | - |
| 165 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.06B | 6.70% | 2,431,579 | 69.64M |
| 166 | AVTX | Avalo Therapeutics, Inc. | 1.02B | 8.33% | 1,244,919 | 59.00K |
| 167 | OLMA | Olema Pharmaceuticals, Inc. | 1.00B | 3.61% | 1,488,388 | - |
| 168 | JANX | Janux Therapeutics, Inc. | 991.61M | 2.65% | 805,838 | 13.73M |
| 169 | VOR | Vor Biopharma Inc. | 980.22M | 4.33% | 999,018 | - |
| 170 | KURA | Kura Oncology, Inc. | 964.09M | -0.28% | 814,981 | 71.64M |
| 171 | ANNX | Annexon, Inc. | 950.29M | -1.53% | 3,341,464 | - |
| 172 | SANA | Sana Biotechnology, Inc. | 944.68M | -0.63% | 2,691,060 | - |
| 173 | PHAR | Pharming Group N.V. | 926.15M | 1.35% | 6,978 | 369.49M |
| 174 | GERN | Geron Corporation | 923.79M | 1.41% | 4,784,001 | 196.12M |
| 175 | ABUS | Arbutus Biopharma Corporation | 900.77M | -3.80% | 1,602,640 | 191.45M |
| 176 | LBRX | LB Pharmaceuticals Inc | 900.73M | 2.68% | 147,919 | - |
| 177 | DBVT | DBV Technologies S.A. | 880.40M | -1.08% | 566,171 | 5.04M |
| 178 | TBPH | Theravance Biopharma, Inc. | 877.45M | -0.24% | 449,526 | 109.78M |
| 179 | PHAT | Phathom Pharmaceuticals, Inc. | 868.97M | -0.27% | 480,187 | 204.89M |
| 180 | REPL | Replimune Group, Inc. | 858.76M | 7.46% | 3,713,343 | - |
| 181 | SLDB | Solid Biosciences Inc. | 858.48M | -3.65% | 1,493,249 | - |
| 182 | ODTX | Odyssey Therapeutics, Inc. | 843.13M | 3.22% | 220,077 | 1.06M |
| 183 | TENX | Tenax Therapeutics, Inc. | 809.80M | 5.11% | 808,315 | - |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 793.29M | 5.97% | 1,253,801 | 8.37M |
| 185 | CTMX | CytomX Therapeutics, Inc. | 788.08M | -1.23% | 3,667,232 | 35.54M |
| 186 | DSGN | Design Therapeutics, Inc. | 785.08M | -0.32% | 468,168 | - |
| 187 | AURA | Aura Biosciences, Inc. | 770.99M | 1.45% | 408,707 | - |
| 188 | DRUG | Bright Minds Biosciences Inc. | 755.06M | 2.55% | 157,446 | - |
| 189 | ZVRA | Zevra Therapeutics, Inc. | 754.90M | 0.08% | 655,698 | 122.29M |
| 190 | RIGL | Rigel Pharmaceuticals, Inc. | 750.07M | -2.71% | 196,505 | 299.77M |
| 191 | CADL | Candel Therapeutics, Inc. | 745.89M | 7.38% | 2,380,160 | - |
| 192 | MNPR | Monopar Therapeutics Inc. | 744.37M | 2.40% | 265,228 | - |
| 193 | NGNE | Neurogene Inc. | 743.47M | 2.22% | 473,445 | 925.00K |
| 194 | OCS | Oculis Holding AG | 736.13M | -3.33% | 304,143 | 1.40M |
| 195 | IMMX | Immix Biopharma, Inc. | 729.70M | 1.89% | 1,058,309 | - |
| 196 | CLYM | Climb Bio, Inc. | 727.21M | 0.95% | 1,374,330 | - |
| 197 | OMER | Omeros Corporation | 701.32M | 5.10% | 1,195,534 | 9.89M |
| 198 | SPRY | ARS Pharmaceuticals, Inc. | 695.12M | -6.17% | 2,127,867 | 98.99M |
| 199 | SLBT | SL Science Holding Limited | 694.99M | -0.69% | 156,409 | - |
| 200 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 685.72M | 3.01% | 269,659 | - |
| 201 | GYRE | Gyre Therapeutics, Inc. | 674.51M | -5.76% | 73,973 | 117.05M |
| 202 | FTH | Faeth Therapeutics, Inc. | 666.90M | -0.27% | 98,701 | - |
| 203 | SGP | SpyGlass Pharma, Inc. | 660.98M | -4.77% | 107,379 | - |
| 204 | CRMD | CorMedix Inc. | 660.56M | 1.57% | 694,737 | 400.05M |
| 205 | ACHV | Achieve Life Sciences, Inc. | 643.67M | 5.20% | 1,480,369 | - |
| 206 | MDXG | MiMedx Group, Inc. | 640.47M | -2.93% | 1,194,200 | 389.42M |
| 207 | ALLO | Allogene Therapeutics, Inc. | 617.83M | - | 4,939,744 | 22.00K |
| 208 | TECX | Tectonic Therapeutic, Inc. | 615.14M | 6.36% | 289,263 | - |
| 209 | NVCT | Nuvectis Pharma, Inc. | 603.40M | 2.90% | 331,001 | - |
| 210 | AGMB | AgomAb Therapeutics NV | 592.95M | -2.27% | 57,394 | - |
| 211 | STTK | Shattuck Labs, Inc. | 577.40M | 6.51% | 2,968,973 | 1.00M |
| 212 | FDMT | 4D Molecular Therapeutics, Inc. | 574.52M | 1.38% | 598,912 | 88.24M |
| 213 | PRME | Prime Medicine, Inc. | 565.33M | -2.80% | 3,349,475 | 4.03M |
| 214 | ALT | Altimmune, Inc. | 558.14M | 0.70% | 2,963,769 | 36.00K |
| 215 | RLMD | Relmada Therapeutics, Inc. | 549.62M | -4.03% | 3,236,497 | - |
| 216 | CTNM | Contineum Therapeutics, Inc. | 532.01M | 1.57% | 145,331 | - |
| 217 | ASMB | Assembly Biosciences, Inc. | 531.30M | 3.75% | 312,835 | 71.10M |
| 218 | VSTM | Verastem, Inc. | 529.88M | 4.51% | 3,562,398 | 49.59M |
| 219 | EIKN | Eikon Therapeutics, Inc. | 528.93M | -1.81% | 181,174 | - |
| 220 | ZURA | Zura Bio Limited | 517.74M | 3.81% | 758,448 | - |
| 221 | ARVN | Arvinas, Inc. | 516.81M | -0.25% | 519,865 | 89.40M |
| 222 | DNA | Ginkgo Bioworks Holdings, Inc. | 516.72M | -4.58% | 1,158,383 | 151.40M |
| 223 | RGNX | REGENXBIO Inc. | 511.30M | -11.70% | 7,516,947 | 87.82M |
| 224 | SLN | Silence Therapeutics plc | 495.96M | -3.85% | 277,230 | 839.00K |
| 225 | CBIO | Crescent Biopharma, Inc. | 490.13M | -2.38% | 318,206 | 11.88M |
| 226 | PROK | ProKidney Corp. | 489.34M | 0.62% | 991,348 | 889.00K |
| 227 | SGMT | Sagimet Biosciences Inc. | 482.90M | 2.22% | 1,381,534 | - |
| 228 | RZLT | Rezolute, Inc. | 481.59M | 5.49% | 1,084,749 | - |
| 229 | ARTV | Artiva Biotherapeutics, Inc. | 474.22M | 7.96% | 360,176 | 251.00K |
| 230 | VALN | Valneva SE | 467.88M | -1.57% | 50,813 | 180.25M |
| 231 | CABA | Cabaletta Bio, Inc. | 461.45M | 5.99% | 3,508,396 | - |
| 232 | ANL | Adlai Nortye Ltd. | 461.20M | 1.59% | 569,048 | 5.00M |
| 233 | OCGN | Ocugen, Inc. | 460.39M | -0.73% | 3,844,189 | 4.47M |
| 234 | EDIT | Editas Medicine, Inc. | 457.32M | 3.47% | 1,749,443 | 38.69M |
| 235 | OVID | Ovid Therapeutics Inc. | 455.40M | -0.41% | 1,065,364 | 7.12M |
| 236 | PRTA | Prothena Corporation plc | 453.38M | 2.24% | 408,386 | 57.94M |
| 237 | KYTX | Kyverna Therapeutics, Inc. | 452.92M | 0.13% | 874,267 | - |
| 238 | HELP | Cybin Inc. | 449.38M | 2.98% | 3,109,300 | - |
| 239 | BNTC | Benitec Biopharma Inc. | 439.05M | 0.95% | 82,200 | - |
| 240 | EVMN | Evommune, Inc. | 437.26M | 3.67% | 769,861 | 10.00M |
| 241 | PBYI | Puma Biotechnology, Inc. | 434.17M | 1.55% | 256,264 | 227.18M |
| 242 | EPRX | Eupraxia Pharmaceuticals Inc. | 432.25M | 6.98% | 118,394 | - |
| 243 | PRLD | Prelude Therapeutics Incorporated | 416.55M | 0.48% | 180,698 | 16.72M |
| 244 | VTVT | vTv Therapeutics Inc. | 408.02M | 1.83% | 77,097 | 36.84M |
| 245 | CCCC | C4 Therapeutics, Inc. | 407.99M | 3.07% | 2,457,932 | 34.86M |
| 246 | IPSC | Century Therapeutics, Inc. | 405.80M | -0.44% | 1,103,959 | 109.16M |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 399.54M | 4.17% | 189,866 | 69.21M |
| 248 | ABEO | Abeona Therapeutics Inc. | 398.97M | -0.28% | 777,459 | 14.54M |
| 249 | DMAC | DiaMedica Therapeutics Inc. | 393.35M | 2.38% | 199,806 | - |
| 250 | STRO | Sutro Biopharma, Inc. | 390.57M | -0.67% | 330,667 | 99.61M |
| 251 | AVIR | Atea Pharmaceuticals, Inc. | 389.73M | 3.29% | 225,627 | - |
| 252 | LRMR | Larimar Therapeutics, Inc. | 386.22M | 0.82% | 1,389,141 | - |
| 253 | AUTL | Autolus Therapeutics plc | 383.25M | -1.37% | 760,293 | 92.62M |
| 254 | UPB | Upstream Bio, Inc. | 381.48M | -3.04% | 378,033 | 3.32M |
| 255 | RCKT | Rocket Pharmaceuticals, Inc. | 375.63M | 0.88% | 1,481,342 | - |
| 256 | CMPX | Compass Therapeutics, Inc. | 369.18M | -2.38% | 2,143,118 | 850.00K |
| 257 | LXEO | Lexeo Therapeutics, Inc. | 368.27M | 2.85% | 730,135 | - |
| 258 | FENC | Fennec Pharmaceuticals Inc. | 364.74M | 0.57% | 186,785 | 51.00M |
| 259 | ZNTL | Zentalis Pharmaceuticals, Inc. | 363.76M | 11.82% | 3,554,226 | 26.87M |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 360.30M | -0.26% | 461,941 | 9.01M |
| 261 | IKT | Inhibikase Therapeutics, Inc. | 359.59M | 4.98% | 1,735,685 | 1.00 |
| 262 | PALI | Palisade Bio, Inc. | 341.95M | 4.23% | 2,097,892 | - |
| 263 | VCRE | Vicore Pharma Holding AB (publ) | 331.80M | 1.03% | 4,116 | 370.61K |
| 264 | VNDA | Vanda Pharmaceuticals Inc. | 327.14M | -0.18% | 888,722 | 217.78M |
| 265 | FATE | Fate Therapeutics, Inc. | 324.03M | 1.83% | 1,692,628 | 6.32M |
| 266 | ELDN | Eledon Pharmaceuticals, Inc. | 314.62M | 5.99% | 787,620 | - |
| 267 | LYEL | Lyell Immunopharma, Inc. | 310.81M | -4.10% | 168,671 | 31.00K |
| 268 | OABI | OmniAb, Inc. | 307.34M | 3.92% | 500,399 | 28.94M |
| 269 | FHTX | Foghorn Therapeutics Inc. | 304.73M | 2.37% | 408,288 | 28.22M |
| 270 | IMRX | Immuneering Corporation | 300.20M | -2.93% | 1,449,200 | - |
| 271 | NMRA | Neumora Therapeutics, Inc. | 298.31M | 0.63% | 1,049,603 | - |
| 272 | BCYC | Bicycle Therapeutics plc | 293.91M | 0.72% | 183,315 | 63.50M |
| 273 | LCTX | Lineage Cell Therapeutics, Inc. | 289.19M | -0.85% | 856,248 | 14.78M |
| 274 | INDP | Indaptus Therapeutics, Inc. | 286.50M | - | 17,345 | - |
| 275 | MGNX | MacroGenics, Inc. | 285.40M | 8.98% | 1,031,733 | 157.08M |
| 276 | ALXO | ALX Oncology Holdings Inc. | 282.58M | 1.45% | 765,313 | - |
| 277 | GALT | Galectin Therapeutics Inc. | 274.95M | -1.18% | 413,756 | - |
| 278 | IFRX | InflaRx N.V. | 273.23M | -2.88% | 749,225 | 33.82K |
| 279 | SLGL | Sol-Gel Technologies Ltd. | 271.98M | 6.56% | 40,555 | 18.47M |
| 280 | TTRX | Turn Therapeutics Inc. | 271.67M | 1.00% | 104,611 | - |
| 281 | SABS | SAB Biotherapeutics, Inc. | 270.68M | -3.41% | 678,367 | 114.70K |
| 282 | IRD | Opus Genetics, Inc. | 269.99M | -0.30% | 507,528 | 11.98M |
| 283 | CNXU | Conexeu Sciences Inc. | 263.03M | -6.47% | 107,589 | - |
| 284 | NAGE | Niagen Bioscience, Inc. | 261.78M | -3.53% | 582,307 | 130.42M |
| 285 | QTTB | Q32 Bio Inc. | 255.19M | -1.05% | 1,316,204 | 53.74M |
| 286 | SRZN | Surrozen, Inc. | 254.96M | 5.83% | 144,920 | 7.49M |
| 287 | TRDA | Entrada Therapeutics, Inc. | 248.27M | 0.29% | 378,188 | 5.74M |
| 288 | FULC | Fulcrum Therapeutics, Inc. | 243.21M | 4.29% | 2,304,782 | 80.00M |
| 289 | RNAC | Cartesian Therapeutics, Inc. | 242.69M | -0.84% | 145,322 | 1.78M |
| 290 | PRQR | ProQR Therapeutics N.V. | 239.91M | 1.80% | 676,768 | 15.73M |
| 291 | GLSI | Greenwich LifeSciences, Inc. | 239.55M | -14.15% | 333,828 | - |
| 292 | ADAG | Adagene Inc. | 237.20M | 0.28% | 249,589 | 7.67M |
| 293 | TARA | Protara Therapeutics, Inc. | 230.44M | 0.49% | 441,523 | - |
| 294 | CGEN | Compugen Ltd. | 224.17M | 1.72% | 154,849 | 72.66M |
| 295 | AVXL | Anavex Life Sciences Corp. | 221.49M | 2.14% | 1,921,051 | - |
| 296 | NAUT | Nautilus Biotechnology, Inc. | 221.12M | 6.10% | 870,899 | - |
| 297 | OBIO | Orchestra BioMed Holdings, Inc. | 220.36M | -1.08% | 200,318 | 32.72M |
| 298 | IVVD | Invivyd, Inc. | 218.75M | -5.76% | 2,109,911 | 55.87M |
| 299 | ACIU | AC Immune SA | 218.24M | 0.92% | 356,184 | 4.62M |
| 300 | CHRS | Coherus Oncology, Inc. | 215.95M | 0.72% | 575,760 | 46.88M |
| 301 | KPTI | Karyopharm Therapeutics Inc. | 215.52M | 1.39% | 205,243 | 151.12M |
| 302 | KROS | Keros Therapeutics, Inc. | 210.59M | 0.28% | 142,831 | 33.18M |
| 303 | WHWK | Whitehawk Therapeutics, Inc. | 209.22M | - | 275,114 | 7.15M |
| 304 | AGEN | Agenus Inc. | 208.63M | 0.20% | 1,754,750 | 123.87M |
| 305 | RNA | Atrium Therapeutics, Inc. | 207.83M | -0.08% | 122,261 | 36.68M |
| 306 | IMUX | Immunic, Inc. | 206.50M | 0.86% | 214,593 | - |
| 307 | NBP | NovaBridge Biosciences | 205.85M | -0.56% | 217,424 | - |
| 308 | CDXS | Codexis, Inc. | 203.61M | 3.70% | 404,525 | 78.09M |
| 309 | DTIL | Precision BioSciences, Inc. | 203.06M | -5.41% | 300,708 | 45.07M |
| 310 | NERV | Minerva Neurosciences, Inc. | 198.93M | 1.43% | 169,909 | - |
| 311 | TNXP | Tonix Pharmaceuticals Holding Corp. | 198.14M | 4.89% | 697,002 | 17.56M |
| 312 | CAMP | Camp4 Therapeutics Corporation | 192.64M | -4.87% | 355,546 | 3.93M |
| 313 | CLLS | Cellectis S.A. | 191.91M | -1.50% | 8,105 | 75.11M |
| 314 | PLX | Protalix BioTherapeutics, Inc. | 191.76M | 3.03% | 549,894 | 76.38M |
| 315 | VYGR | Voyager Therapeutics, Inc. | 191.54M | 4.28% | 924,225 | 36.49M |
| 316 | MDWD | MediWound Ltd. | 187.77M | - | 44,898 | 14.48M |
| 317 | NKTX | Nkarta, Inc. | 186.02M | - | 328,077 | - |
| 318 | ACOG | Alpha Cognition Inc. | 185.08M | 1.80% | 40,993 | 10.83M |
| 319 | HUMA | Humacyte, Inc. | 179.23M | 0.77% | 4,008,281 | 2.02M |
| 320 | NRXP | NRx Pharmaceuticals, Inc. | 178.96M | 0.71% | 425,826 | 2.29M |
| 321 | CNTN | Canton Strategic Holdings, Inc. | 177.38M | -1.71% | 451,198 | - |
| 322 | NGEN | NervGen Pharma Corp. | 177.36M | - | 858,349 | - |
| 323 | TNYA | Tenaya Therapeutics, Inc. | 177.29M | -2.46% | 1,767,865 | 225.00K |
| 324 | KRRO | Korro Bio, Inc. | 176.68M | -0.24% | 169,771 | 3.84M |
| 325 | YDES | YD Bio Limited | 172.28M | -0.41% | 19,924 | 510.36K |
| 326 | ARCT | Arcturus Therapeutics Holdings Inc. | 171.96M | -2.10% | 429,587 | 54.71M |
| 327 | OKUR | OnKure Therapeutics, Inc. | 169.66M | 2.44% | 73,291 | - |
| 328 | ANTX | AN2 Therapeutics, Inc. | 168.56M | 0.21% | 66,084 | - |
| 329 | OTLK | Outlook Therapeutics, Inc. | 168.00M | -4.79% | 9,661,562 | 333.14K |
| 330 | MENS | Jyong Biotech Ltd. | 167.77M | -1.74% | 53,178 | - |
| 331 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 166.94M | 2.39% | 216,008 | - |
| 332 | ALEC | Alector, Inc. | 166.54M | 2.04% | 500,157 | 18.42M |
| 333 | ARMP | Armata Pharmaceuticals, Inc. | 165.57M | 19.95% | 271,344 | 5.20M |
| 334 | ORMP | Oramed Pharmaceuticals Inc. | 164.93M | -0.49% | 184,476 | 2.00M |
| 335 | EQ | Equillium, Inc. | 163.76M | 3.60% | 438,986 | 4.39M |
| 336 | CRBU | Caribou Biosciences, Inc. | 163.65M | -0.60% | 1,447,862 | 11.20M |
| 337 | ABOS | Acumen Pharmaceuticals, Inc. | 162.51M | 3.69% | 306,048 | - |
| 338 | LENZ | LENZ Therapeutics, Inc. | 162.42M | 6.15% | 1,116,591 | 20.99M |
| 339 | IPHA | Innate Pharma S.A. | 161.91M | -1.41% | 10,432 | 10.57M |
| 340 | MIST | Milestone Pharmaceuticals Inc. | 161.22M | -4.44% | 1,571,529 | 1.78M |
| 341 | PEPG | PepGen Inc. | 155.63M | - | 609,057 | - |
| 342 | KZIA | Kazia Therapeutics Limited | 152.43M | 1.68% | 95,834 | 1.27M |
| 343 | CNTB | Connect Biopharma Holdings Limited | 149.85M | 1.93% | 381,231 | 233.00K |
| 344 | PYXS | Pyxis Oncology, Inc. | 149.52M | 5.83% | 380,733 | 13.86M |
| 345 | UNCY | Unicycive Therapeutics, Inc. | 147.37M | 6.53% | 1,345,975 | - |
| 346 | MOLN | Molecular Partners AG | 146.99M | -4.88% | 2,187 | 856.30K |
| 347 | HURA | TuHURA Biosciences, Inc. | 143.29M | 1.35% | 162,494 | - |
| 348 | TLSA | Tiziana Life Sciences Ltd | 138.36M | -2.73% | 140,806 | - |
| 349 | CBUS | Cibus, Inc. | 136.63M | -1.10% | 206,216 | 4.29M |
| 350 | PMN | ProMIS Neurosciences, Inc. | 136.22M | 14.21% | 132,985 | - |
| 351 | CUE | Cue Biopharma, Inc. | 130.88M | 12.13% | 122,644 | 32.73M |
| 352 | GUTS | Fractyl Health, Inc. | 128.51M | -5.19% | 1,437,471 | 3.00K |
| 353 | AARD | Aardvark Therapeutics, Inc. | 127.84M | -7.42% | 233,614 | - |
| 354 | GNLX | Genelux Corporation | 127.45M | 1.77% | 77,178 | 8.00K |
| 355 | ENGN | enGene Therapeutics Inc. | 121.92M | -5.21% | 798,872 | - |
| 356 | SPRB | Spruce Biosciences, Inc. | 119.83M | -1.67% | 74,249 | 697.00K |
| 357 | SEER | Seer, Inc. | 119.31M | 0.46% | 121,486 | 15.17M |
| 358 | ANIX | Anixa Biosciences, Inc. | 115.68M | 2.41% | 175,571 | - |
| 359 | VANI | Vivani Medical, Inc. | 113.83M | -2.22% | 470,373 | - |
| 360 | FBIO | Fortress Biotech, Inc. | 111.62M | -1.75% | 304,027 | 66.16M |
| 361 | PLYX | Polaryx Therapeutics, Inc. | 107.94M | -1.30% | 58,013 | - |
| 362 | COYA | Coya Therapeutics, Inc. | 106.50M | -1.30% | 361,180 | 7.94M |
| 363 | KLRS | Kalaris Therapeutics, Inc. | 104.21M | -4.99% | 10,944,041 | - |
| 364 | PYPD | PolyPid Ltd. | 102.96M | 3.47% | 241,797 | - |
| 365 | BDTX | Black Diamond Therapeutics, Inc. | 102.57M | -1.10% | 708,210 | 70.00M |
| 366 | ALDX | Aldeyra Therapeutics, Inc. | 101.94M | -1.74% | 1,170,612 | - |
| 367 | ONCY | Oncolytics Biotech Inc. | 101.84M | -3.37% | 1,230,017 | - |
| 368 | ICCC | ImmuCell Corporation | 100.65M | -0.04% | 9,098 | 29.93M |
| 369 | ENTX | Entera Bio Ltd. | 97.59M | -1.00% | 247,116 | 42.00K |
| 370 | VRCA | Verrica Pharmaceuticals Inc. | 96.03M | 0.54% | 48,995 | 37.16M |
| 371 | PTHS | Pelthos Therapeutics Inc. | 93.81M | 1.05% | 9,899 | 27.70M |
| 372 | BMEA | Biomea Fusion, Inc. | 92.54M | 1.59% | 523,945 | - |
| 373 | INO | Inovio Pharmaceuticals, Inc. | 92.15M | - | 829,487 | 65.34K |
| 374 | SPRO | Spero Therapeutics, Inc. | 91.48M | 0.64% | 1,249,349 | 61.19M |
| 375 | NTHI | NeOnc Technologies Holdings, Inc. | 89.73M | 6.46% | 70,928 | 39.99K |
| 376 | ATHE | Alterity Therapeutics Limited | 89.61M | -2.16% | 9,374 | 4.43M |
| 377 | HRTX | Heron Therapeutics, Inc. | 89.09M | -1.11% | 1,677,913 | 150.71M |
| 378 | RLYB | Rallybio Corporation | 87.00M | 2.88% | 48,202 | 858.00K |
| 379 | RANI | Rani Therapeutics Holdings, Inc. | 86.38M | 4.09% | 1,195,568 | 3.17M |
| 380 | CGTX | Cognition Therapeutics, Inc. | 85.99M | 2.21% | 468,028 | - |
| 381 | ACET | Adicet Bio, Inc. | 85.27M | -1.22% | 104,892 | - |
| 382 | CSBR | Champions Oncology, Inc. | 85.13M | 4.97% | 11,856 | 57.95M |
| 383 | NRXS | NeurAxis, Inc. | 83.59M | -0.44% | 39,308 | 4.28M |
| 384 | ALPS | Alps Group Inc | 83.20M | 12.36% | 197,029 | 3.74M |
| 385 | GOSS | Gossamer Bio, Inc. | 83.15M | -0.23% | 11,563,920 | 55.54M |
| 386 | RNTX | Rein Therapeutics Inc. | 80.21M | 0.01% | 175,063 | - |
| 387 | MAIA | MAIA Biotechnology, Inc. | 79.04M | -2.26% | 481,677 | - |
| 388 | TELO | Telomir Pharmaceuticals, Inc. | 76.34M | -6.72% | 292,075 | - |
| 389 | ATRA | Atara Biotherapeutics, Inc. | 75.60M | -3.78% | 81,342 | 23.14M |
| 390 | ENLV | Enlivex Ltd. | 75.21M | -1.47% | 118,203 | - |
| 391 | OKYO | OKYO Pharma Limited | 75.05M | 3.62% | 28,694 | - |
| 392 | ACRV | Acrivon Therapeutics, Inc. | 74.90M | - | 238,905 | - |
| 393 | ANVS | Annovis Bio, Inc. | 74.02M | - | 624,199 | - |
| 394 | GANX | Gain Therapeutics, Inc. | 72.94M | 3.01% | 503,233 | - |
| 395 | HYFT | MindWalk Holdings Corp. | 72.51M | 3.55% | 160,494 | 20.70M |
| 396 | PMVP | PMV Pharmaceuticals, Inc. | 71.46M | 3.08% | 167,166 | - |
| 397 | PLRX | Pliant Therapeutics, Inc. | 71.21M | 3.60% | 405,605 | - |
| 398 | XBIT | XBiotech Inc. | 69.21M | -0.87% | 59,105 | - |
| 399 | IBIO | iBio, Inc. | 68.56M | 2.22% | 603,078 | 300.00K |
| 400 | OSTX | OS Therapies Incorporated | 68.14M | 2.00% | 453,304 | - |
| 401 | LONA | LeonaBio, Inc. | 67.82M | -7.55% | 65,060 | - |
| 402 | MNOV | MediciNova, Inc. | 66.45M | -4.93% | 139,137 | 596.64K |
| 403 | CING | Cingulate Inc. | 61.15M | 2.48% | 237,588 | - |
| 404 | IMA | ImageneBio, Inc. | 60.68M | -1.28% | 30,140 | 800.00K |
| 405 | CRDF | Cardiff Oncology, Inc. | 60.17M | 0.63% | 2,134,915 | 525.00K |
| 406 | TCRX | TScan Therapeutics, Inc. | 59.78M | 1.80% | 143,982 | 9.14M |
| 407 | ELTX | Elicio Therapeutics, Inc. | 59.31M | -2.81% | 755,929 | - |
| 408 | EDSA | Edesa Biotech, Inc. | 58.69M | -1.79% | 39,285 | - |
| 409 | BOLD | Boundless Bio, Inc. | 55.71M | -0.40% | 102,934 | - |
| 410 | CNTX | Context Therapeutics Inc. | 55.13M | -2.38% | 746,826 | - |
| 411 | VRXA | Veraxa Biotech AG | 54.97M | 6.34% | 254,025 | - |
| 412 | XLO | Xilio Therapeutics, Inc. | 53.13M | -1.66% | 55,718 | 53.48M |
| 413 | INKT | MiNK Therapeutics, Inc. | 53.11M | -1.39% | 25,365 | - |
| 414 | BYSI | BeyondSpring Inc. | 53.04M | 0.78% | 14,158 | 1.88M |
| 415 | MCRB | Seres Therapeutics, Inc. | 51.62M | 2.90% | 56,362 | 1.15M |
| 416 | IMMP | Immutep Limited | 51.45M | -5.92% | 390,152 | 5.28M |
| 417 | FLNA | Filana Therapeutics, Inc. | 51.21M | -1.85% | 164,797 | - |
| 418 | EXOZ | eXoZymes, Inc. | 51.04M | -3.22% | 8,144 | -700.00 |
| 419 | INMB | INmune Bio Inc. | 50.51M | -8.21% | 802,922 | 50.00K |
| 420 | TIL | Instil Bio, Inc. | 50.32M | -1.20% | 9,108 | - |
| 421 | ATYR | aTyr Pharma, Inc. | 49.99M | -1.18% | 713,496 | 190.00K |
| 422 | MREO | Mereo BioPharma Group plc | 49.50M | -3.93% | 476,606 | 500.00K |
| 423 | RADX | Radiopharm Theranostics Limited | 49.50M | 3.26% | 31,917 | 10.86M |
| 424 | IBO | Impact BioMedical Inc. | 49.17M | - | 16,838 | 39.00K |
| 425 | ELOX | Eloxx Pharmaceuticals, Inc. | 48.44M | -0.17% | 28,419 | - |
| 426 | MGX | Metagenomi Therapeutics, Inc. | 46.68M | - | 127,408 | 22.33M |
| 427 | DWTX | Dogwood Therapeutics, Inc. | 46.41M | 0.73% | 73,869 | - |
| 428 | DYAI | Dyadic International, Inc. | 45.91M | 5.88% | 136,137 | 3.81M |
| 429 | CRVO | CervoMed Inc. | 41.66M | -1.91% | 204,112 | 2.09M |
| 430 | HYPD | Hyperion DeFi, Inc. | 41.53M | -0.36% | 296,800 | 1.04M |
| 431 | PDSB | PDS Biotechnology Corporation | 41.02M | 3.33% | 250,839 | - |
| 432 | APLM | Apollomics, Inc. | 40.67M | -20.41% | 19,200 | 8.84M |
| 433 | GRCE | Grace Therapeutics, Inc. | 40.20M | 2.49% | 122,539 | - |
| 434 | NNVC | NanoViricides, Inc. | 39.87M | -1.13% | 176,579 | - |
| 435 | RNXT | RenovoRx, Inc. | 39.02M | -1.78% | 112,223 | 1.49M |
| 436 | VERU | Veru Inc. | 38.20M | 1.28% | 89,490 | 16.89M |
| 437 | NTRB | Nutriband Inc. | 37.81M | -0.64% | 13,447 | 1.80M |
| 438 | LTRN | Lantern Pharma Inc. | 36.62M | -1.37% | 106,248 | - |
| 439 | GNTA | Genenta Science S.p.A. | 36.57M | 7.64% | 104,430 | - |
| 440 | ESLA | Estrella Immunopharma, Inc. | 36.15M | 13.19% | 253,529 | - |
| 441 | ALGS | Aligos Therapeutics, Inc. | 35.52M | -0.17% | 47,416 | 4.71M |
| 442 | ACTU | Actuate Therapeutics, Inc. | 34.45M | -13.25% | 177,446 | - |
| 443 | LITS | Lite Strategy, Inc. | 33.57M | 1.69% | 73,434 | - |
| 444 | LSTA | Lisata Therapeutics, Inc. | 32.74M | 2.71% | 64,287 | 170.00K |
| 445 | BCTX | BriaCell Therapeutics Corp. | 32.66M | -3.12% | 87,912 | - |
| 446 | SER | Serina Therapeutics, Inc. | 31.94M | 7.58% | 29,240 | 130.00K |
| 447 | ABVC | ABVC BioPharma, Inc. | 31.59M | 3.31% | 88,897 | 797.92K |
| 448 | TVRD | Tvardi Therapeutics, Inc. | 30.02M | 3.90% | 972,447 | - |
| 449 | DARE | Daré Bioscience, Inc. | 29.36M | 1.03% | 100,932 | 1.16M |
| 450 | KYNB | Kyntra Bio, Inc. | 29.27M | -2.17% | 9,444 | 7.44M |
| 451 | ATNM | Actinium Pharmaceuticals, Inc. | 28.92M | 3.58% | 56,470 | 90.00K |
| 452 | IGC | IGC Pharma, Inc. | 26.02M | 1.44% | 238,607 | 1.11M |
| 453 | PSTV | Plus Therapeutics, Inc. | 25.74M | -4.10% | 215,179 | 5.18M |
| 454 | EVAX | Evaxion A/S | 25.65M | -1.44% | 13,970 | 7.53M |
| 455 | GRDX | GridAI Technologies Corp. | 25.41M | 0.26% | 33,823 | - |
| 456 | VYNE | VYNE Therapeutics Inc. | 25.38M | -0.85% | 1,005,191 | 454.00K |
| 457 | PLRZ | Polyrizon Ltd. | 25.12M | 3.23% | 8,289 | - |
| 458 | JSPR | Jasper Therapeutics, Inc. | 24.78M | 14.34% | 29,907,281 | - |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 24.18M | -2.61% | 55,333 | - |
| 460 | SKYE | Skye Bioscience, Inc. | 22.82M | 3.29% | 97,306 | - |
| 461 | BRNS | Barinthus Biotherapeutics plc | 22.69M | -17.09% | 40,374 | 14.97M |
| 462 | CELU | Celularity Inc. | 22.59M | 1.59% | 16,925 | 26.55M |
| 463 | NCEL | NewcelX Ltd. | 22.02M | 4.60% | 14,223 | - |
| 464 | MRKR | Marker Therapeutics, Inc. | 21.84M | -2.24% | 30,878 | 3.55M |
| 465 | NXTC | NextCure, Inc. | 21.64M | -2.92% | 817,422 | - |
| 466 | ATOS | Atossa Therapeutics, Inc. | 21.44M | 4.18% | 47,874 | - |
| 467 | QNTM | Quantum BioPharma Ltd. | 20.55M | -3.86% | 100,956 | - |
| 468 | CVM | CEL-SCI Corporation | 20.45M | 1.74% | 455,340 | - |
| 469 | PLUR | Pluri Inc. | 20.07M | 3.33% | 37,334 | 1.08M |
| 470 | CLRB | Cellectar Biosciences, Inc. | 20.06M | -2.71% | 50,487 | - |
| 471 | LGVN | Longeveron Inc. | 19.65M | 1.40% | 202,177 | 1.22M |
| 472 | AKTX | Akari Therapeutics, Plc | 19.27M | -4.26% | 42,193 | - |
| 473 | ALLR | Allarity Therapeutics, Inc. | 18.93M | 1.71% | 82,892 | 345.00K |
| 474 | QNCX | Quince Therapeutics, Inc. | 18.46M | 1.12% | 40,314 | - |
| 475 | NEUP | Neuphoria Therapeutics Inc. | 18.46M | -3.26% | 46,837 | -13.27K |
| 476 | LPCN | Lipocine Inc. | 18.38M | -2.62% | 20,673 | 2.00M |
| 477 | HOWL | Werewolf Therapeutics, Inc. | 17.88M | 0.03% | 340,135 | 1.14M |
| 478 | TVGN | Tevogen Bio Holdings Inc. | 17.76M | -4.54% | 8,821 | - |
| 479 | PTN | Palatin Technologies, Inc. | 17.12M | 7.19% | 23,487 | 12.88M |
| 480 | OSRH | OSR Health, Inc. | 16.40M | -3.79% | 1,175,730 | 2.63M |
| 481 | ICU | SeaStar Medical Holding Corporation | 16.08M | -5.21% | 77,077 | 1.44M |
| 482 | LEXX | Lexaria Bioscience Corp. | 15.77M | 13.71% | 131,258 | 194.00K |
| 483 | PASG | Passage Bio, Inc. | 15.49M | -1.63% | 55,431 | - |
| 484 | CYCN | Cyclerion Therapeutics, Inc. | 15.44M | -0.55% | 18,141 | 1.99M |
| 485 | HIND | Vyome Holdings, Inc. | 15.09M | -1.83% | 10,008 | 152.72K |
| 486 | KTTA | Pasithea Therapeutics Corp. | 15.04M | -1.57% | 195,590 | - |
| 487 | KALA | KALA BIO, Inc. | 14.42M | -8.42% | 188,266 | - |
| 488 | TPST | Tempest Therapeutics, Inc. | 14.30M | -1.04% | 207,596 | - |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 13.61M | -2.88% | 286,628 | 5.61M |
| 490 | SNTI | Senti Biosciences Holdings, Inc. | 13.61M | -4.94% | 408,426 | 38.00K |
| 491 | MLEC | Moolec Science SA | 13.61M | -6.57% | 2,759 | 7.83M |
| 492 | BIVI | BioVie Inc. | 13.58M | 4.65% | 130,354 | - |
| 493 | COCP | Cocrystal Pharma, Inc. | 13.10M | -0.01% | 12,079 | 225.00K |
| 494 | INAB | IN8bio, Inc. | 13.10M | -3.62% | 65,505 | - |
| 495 | INTS | Intensity Therapeutics, Inc. | 12.84M | -3.06% | 19,767 | - |
| 496 | GTBP | GT Biopharma, Inc. | 12.83M | -7.20% | 497,901 | - |
| 497 | LNAI | Lunai Bioworks Inc. | 12.79M | -2.08% | 15,889 | 20.94K |
| 498 | BLRX | BioLineRx Ltd. | 12.07M | -2.68% | 6,376 | 1.40M |
| 499 | PHIO | Phio Pharmaceuticals Corp. | 11.97M | 3.01% | 759,539 | - |
| 500 | GDTC | CytoMed Therapeutics Limited | 11.83M | -1.96% | 9,132 | 669.28K |